These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34202411)

  • 21. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy.
    Taeb S; Ashrafizadeh M; Zarrabi A; Rezapoor S; Musa AE; Farhood B; Najafi M
    Curr Cancer Drug Targets; 2022; 22(1):18-30. PubMed ID: 34951575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers.
    Chan TS; Shaked Y; Tsai KK
    Front Oncol; 2019; 9():688. PubMed ID: 31417869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.
    Lee PJ; Ho CC; Ho H; Chen WJ; Lin CH; Lai YH; Juan YC; Chu WC; Lee JH; Su SF; Chen HY; Chen JJW; Chang GC; Li KC; Yang PC; Chen HW
    Theranostics; 2021; 11(19):9667-9686. PubMed ID: 34646392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer stem cells as key drivers of tumour progression.
    Ayob AZ; Ramasamy TS
    J Biomed Sci; 2018 Mar; 25(1):20. PubMed ID: 29506506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy.
    Ravindran S; Rasool S; Maccalli C
    Cancer Microenviron; 2019 Dec; 12(2-3):133-148. PubMed ID: 31758404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities.
    Turdo A; Porcelli G; D'Accardo C; Franco SD; Verona F; Forte S; Giuffrida D; Memeo L; Todaro M; Stassi G
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response.
    Huang JL; Chen SY; Lin CS
    J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
    Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
    Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
    Singh D; Khan MA; Siddique HR
    Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment.
    Kilmister EJ; Koh SP; Weth FR; Gray C; Tan ST
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications.
    Lau EY; Ho NP; Lee TK
    Stem Cells Int; 2017; 2017():3714190. PubMed ID: 28337221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The strategies to cure cancer patients by eradicating cancer stem-like cells.
    Mai Y; Su J; Yang C; Xia C; Fu L
    Mol Cancer; 2023 Oct; 22(1):171. PubMed ID: 37853413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs.
    Osman A; Afify SM; Hassan G; Fu X; Seno A; Seno M
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy.
    Kaur J; Bhattacharyya S
    Front Oncol; 2021; 11():756888. PubMed ID: 34804950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutting the umbilical cord: Cancer stem cell-targeted therapeutics.
    Banik A; Sharma R; Chauhan A; Singh S
    Life Sci; 2022 Jun; 299():120502. PubMed ID: 35351466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.
    Müller L; Tunger A; Plesca I; Wehner R; Temme A; Westphal D; Meier F; Bachmann M; Schmitz M
    Front Immunol; 2020; 11():140. PubMed ID: 32117287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.
    Khosravi N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Shahgoli VK; Hemmat N; Safarzadeh E; Baradaran B
    Life Sci; 2020 Sep; 256():118005. PubMed ID: 32593711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment.
    Sipos F; Műzes G
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.